JDRF Partners with CoMentis for Diabetic Macular Edema Clinical Trial
September 20, 2007
Read More...

CoMentis Receives FDA Clearance to Begin Human Clinical Trials
June 18, 2007
Read More...

CoMentis Announces Appointment of Martin Tolar, M.D., Ph.D., as Vice President
June 06, 2007
Read More...

CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
April 10, 2007
Read More...

Athenagen Announces Name Change to CoMentis
February 20, 2007
Read More...

Athenagen’s Eye Drop Therapy for AMD is Safe and Well Tolerated in Phase I Study
January 30, 2007
Read More...